The translation is incomplete; switch to the original for the full text.
,/PRNewswire/ -- 雅宝(Albemarle Corporation)(NYSE: ALB)是为出行、能源、连接和健康提供关键要素的全球领导者,今日公布了截至2026年6月30日的第二季度业绩。
2026年第二季度及近期亮点
(除另有说明外,所有百分比变动均为同比比较,且未剔除Ketjen炼油催化剂解决方案业务上一期间的业绩;公司已于2026年3月2日出售该业务51%的股权)
- 净销售额17亿美元,增长31%,原因是储能业务定价提高(+73%)以及特种产品业务定价和销量均上升(价格+11%,销量+8%)。
- 归属于普通股股东的净利润为4.8亿美元,即每股摊薄收益3.52美元。
- 调整后EBITDA(a) 为8.58亿美元;增长155%,主要由于储能业务定价上升、特种业务定价和销量增长以及持续的成本和生产率改善。调整后EBITDA在储能(+229%)和特种(+61%)两项业务中均实现增长。
- 经营活动产生的现金为7.10亿美元,自由现金流为6.38亿美元(a)。经营现金流转化率为83%(a),主要受Talison合资企业股息增加的时间安排以及非经常性营运资金收益的推动。
- 年初至今已实现1亿美元的年化成本与生产率改善,正朝着我们全年1亿至1.5亿美元目标的高端迈进。经营活动产生的现金为7.1亿美元,自由现金流为6.38亿美元(a)。经营现金流转化率为83%(a),主要得益于Talison合资企业股息增加的时间安排以及非经常性营运资金收益。
- 改善2026年全年展望的考量因素包括:
- 将全年Specialties净销售额展望上调至14亿至16亿美元,调整后EBITDA展望上调至2.75亿至3.25亿美元,原因是年初至今的定价和销量表现强于预期。
- 预计6月9日Talison CGP3火灾对储能销量影响极小,部分原因是Wodgina矿的产量好于计划。
- 由于持续的资本效率改善,将全年资本支出预测下调至约5亿美元。
(a) 详见非GAAP调节表。
“雅宝(Albemarle)本季度再次取得强劲业绩,反映出定价改善、特种产品业务持续强劲、严格的成本与生产率执行以及强劲的现金生成能力,”董事长兼首席执行官Kent Masters表示。“我们继续看到核心市场(包括储能、电动汽车和半导体)的需求基本面保持韧性。我们正在推进价值最高的内生增长机会,同时对资本配置和执行保持严格纪律。”
2026年第二季度业绩 | |||||||
除每股金额外,单位为百万 | 2026年第二季度 | 2025年第二季度 | 金额变动 | 变动百分比 | |||
净销售额 | $ 1,743.3 | $ 1,330.0 | $ 413.3 | 31.1 % | |||
归属于雅宝(Albemarle Corporation)的净利润 | $ 480.0 | $ 22.9 | $ 457.1 | 1,996.2 % | |||
调整后EBITDA(a) | $ 858.1 | $ 336.5 | $ 521.6 | 155.0 % | |||
Diluted income (loss) per share attributable to common | $ 3.52 | $ (0.16) | $ 3.68 | NM | |||
非经常性及其他异常项目(a) | 0.22 | 0.27 | |||||
Adjusted diluted income per share attributable to | $ 3.75 | $ 0.11 | $ 3.64 | NM | |||
(a) 详见非GAAP调节表以了解更多详情。 (b) 由于四舍五入,总计可能无法相加。 | |||||||
2026年第二季度净销售额为17亿美元,上年同期为13亿美元,增长31%,主要受储能和特种材料两大业务价格上涨以及特种材料销量增长推动。调整后EBITDA为8.58亿美元,较上年同期增加5.22亿美元,主要由于净销售额增长以及持续的成本和生产率改善。
归属于雅宝(Albemarle)的净利润为4.8亿美元,同比增加4.57亿美元。2026年第二季度的有效所得税率为21.3%,按调整后口径计算为19.1%。
储能业务业绩 | |||||||
单位:百万 | 2026年第二季度 | 2025年第二季度 | 变动金额(美元) | 变动百分比 | |||
净销售额 | $ 1,276.7 | $ 717.7 | $ 559.0 | 77.9 % | |||
销售量(千吨碳酸锂当量)(a) | 65 | 59 | 6 | 11.0 % | |||
平均实现价格(美元/千克碳酸锂当量)(a) | $ 19.53 | $ 12.17 | $ 7.36 | 60.5 % | |||
调整后EBITDA | $ 723.5 | $ 219.7 | $ 503.7 | 229.3 % | |||
(a) 包括按碳酸锂当量(LCE)计算的汇总盐类和锂辉石销量。 | |||||||
2026年第二季度储能业务净销售额为13亿美元,增加5.59亿美元,增幅78%,主要由于定价上升。调整后EBITDA为7.23亿美元,增加5.04亿美元,增幅229%,主要由于锂定价上升,部分被CORFO特许权使用费增加所抵消。
特种产品业绩 | |||||||
单位:百万 | 2026年第二季度 | 2025年第二季度 | 金额变动 | 变动百分比 | |||
净销售额 | $ 423.5 | $ 351.6 | $ 71.9 | 20.5 % | |||
调整后EBITDA | $ 117.7 | $ 73.0 | $ 44.7 | 61.3 % | |||
2026年第二季度特种产品净销售额为4.23亿美元,增加7200万美元,增幅20%,主要由于销量上升(+8%)和定价上涨(+11%)。调整后EBITDA为1.18亿美元,增加4500万美元,增幅61%,主要由于溴及衍生物销量上升和有利定价,以及持续的生产率改善和对中东冲突导致的成本上涨的主动管理。
2026年展望考量
公司整体展望考量
下表反映了基于近期观察到的锂市场价格情景对公司整体的预期结果。每种情景的展望区间基于销量和产品结构的变化。预计储能产量将同比增长。由于Wodgina产量的增加部分抵消了Talison CGP3因6月9日发生火灾而延迟爬产的影响,销量预计将在22.5万至23.5万吨碳酸锂当量之间。所有三种情景均假设市场价格平稳贯穿储能当前合同簿,其中约40%的盐类销量(即总销量的三分之一)为长期协议。情景还假设锂辉石定价平均为碳酸锂当量(LCE)价格的10%,而其他成本假设保持不变。
公司2026财年预计总计 | |||
观察到的市场价格情形(a) | 2025财年平均 | 2026年第一季度平均 | 2021-2025年平均 |
锂市场平均价格(美元/千克碳酸锂当量)(a) | 约10美元 | 约20美元 | 约30美元 |
净销售额 | 41亿至43亿美元 | 57亿至60亿美元 | 75亿至78亿美元 |
调整后EBITDA(b) | 9亿至10亿美元 | 24亿至26亿美元 | 42亿至44亿美元 |
(a) 价格代表相关市场定价的混合,包括所述期间的现货和区域指数。 (b) 公司不提供前瞻性非GAAP财务指标与按照GAAP计算和报告的最直接可比财务指标之间的调节表,因为公司无法在不付出不合理努力的情况下估计重大非经常性或异常项目。更多信息请参见“关于非GAAP指标的补充信息”。 | |||
储能市场价格情景 | |||
储能 2026财年预测 | |||
观察到的市场价格情形(a) | 2025财年平均 | 2026年第一季度平均 | 2021-2025年平均 |
锂市场平均价格(美元/千克碳酸锂当量)(a) | 约10美元 | 约20美元 | 约30美元 |
净销售额 | 25亿至26亿美元 | 40亿至42亿美元 | 59亿至61亿美元 |
调整后EBITDA | 7亿至8亿美元 | 21亿至23亿美元 | 39亿至41亿美元 |
未合并投资的净收益权益 | 2亿至3亿美元 | 6亿至7亿美元 | 10亿至11亿美元 |
(a) 价格代表相关市场定价的混合,包括所述期间的现货和区域指数。 (b) 按税前基础计入调整后EBITDA。 | |||
特种产品业务展望考量
特种产品业务的净销售额和调整后EBITDA展望有所改善,主要得益于年初至今的强劲表现,这由溴素特种产品的销量增长以及成本和生产率改善所驱动。我们的展望继续反映关键终端市场的温和销量增长,主要由半导体、石油和天然气、阻燃剂和制药领域引领,但部分被汽车和石化领域预期的疲软所抵消。下半年展望假设溴素市场趋于稳定,并持续存在不确定性,包括中东局势。Jordan Bromine Company(JBC)合资企业的运营符合预期,该公司继续应对该地区的地缘政治紧张局势。
2026财年分部预期 | |
特种产品净销售额 | 14亿至16亿美元 |
特种产品调整后EBITDA | 2.75亿至3.25亿美元 |
其他公司展望考量
雅宝(Albemarle)预计其2026年全年资本支出约为5亿美元,由于持续的资本效率提升,较2025年下降15%。
继2026年3月2日宣布出售Ketjen炼油催化剂解决方案业务控股权后,炼油催化剂业务的收益现归类为权益收益并计入公司及其他(Corporate),保留的Performance Catalyst Solutions(PCS)业务的业绩亦同样计入。交易完成后,上述业务对调整后EBITDA和权益收益的贡献预计将不重大。
在2026年第一季度完成债务削减行动后,预计2026年的利息和融资费用将在1.2亿美元至1.4亿美元之间。
其他企业 2026财年预计 | |
资本支出 | 约5亿美元 |
折旧与摊销 | 6.6亿至6.8亿美元 |
调整后有效税率(a) | (50)% - 30% |
公司调整后EBITDA(含外汇、Ketjen权益收益及PCS) | (20)至20百万美元 |
利息和融资费用 | 1.2亿至1.4亿美元 |
加权平均流通普通股股数(稀释后)(b) | 约1.36亿股 |
(a) 调整后的实际税率取决于锂市场价格和地域收入结构 (b) 稀释加权平均流通普通股股数假设优先股已转换,且归属于普通股股东的净利润不会被强制可转换优先股股息所减少。如果强制可转换优先股股息的减少导致每股收益更具稀释性,则稀释加权平均流通普通股股数将不假设优先股已转换。 | |
现金流与资本配置
2026年上半年经营活动产生的现金流为11亿美元,较上年同期增加5.18亿美元。2026年前六个月资本支出为1.7亿美元,较上年同期减少1.32亿美元。
资产负债表与流动性
截至2026年6月30日,Albemarle(雅宝)的估计流动性约为32亿美元,其中包括16亿美元现金及现金等价物、循环信贷额度下可用的15亿美元以及其他信贷额度下可用的7800万美元。总债务为19亿美元,净债务与调整后EBITDA之比(按我们信贷协议中的定义)约为0.5(a)。
(a) 详见非GAAP调节表。
财报电话会议
日期: | 2026年8月6日,星期四 |
时间: | 美国东部时间上午8:00 |
电话接入(美国): | 1-800-590-8290 |
电话接入(国际): | 1-240-690-8800 |
会议ID: | ALBQ2 |
公司的业绩演示文稿及配套材料可在雅宝(Albemarle)网站 https://investors.albemarle.com 上查阅。
关于雅宝(Albemarle)
雅宝公司(Albemarle Corporation,纽约证券交易所代码:ALB)是将关键资源转化为移动出行、能源、连接和健康领域关键成分的全球领导者。我们携手合作,以兼顾人类与地球的方式,开创移动、供能、连接和保护的新途径。可靠且高质量的全球锂和溴供应使我们能够为客户提供先进解决方案。欲了解更多关于雅宝员工如何助力构建更具韧性的世界的信息,请访问 Albemarle.com。
雅宝(Albemarle)定期在 Albemarle.com 发布信息,包括活动通知、新闻、财务业绩、投资者演示和网络直播、非 GAAP 调节表、美国证券交易委员会(U.S. Securities and Exchange Commission)备案文件,以及有关公司、其业务及其所服务市场的其他信息。
前瞻性陈述
本新闻稿包含有关我们对未来的预期、期望和信念的陈述,这些陈述构成1995年《私人证券诉讼改革法案》意义上的“前瞻性陈述”。这些前瞻性陈述基于我们截至本新闻稿发布之日所作的假设,并受已知和未知风险及不确定性的影响,通常包含诸如“雄心”、“预期”、“相信”、“估计”、“期望”、“目标”、“指引”、“打算”、“可能”、“展望”、“情景”、“应当”、“将会”和“将”等词语。 前瞻性陈述可能包括有关以下内容的陈述:我们2026年公司和业务板块展望,包括碳酸锂当量和锂辉石的预期市场价格以及其他基本假设和展望考量;有关客户需求和销售的计划和预期;产量影响;财务灵活性和可选性;锂、锂辉石、溴和锂特种产品(“公司产品”)的预期或实际市场价格;公司产品的供需;长期需求和增长的驱动因素;其他基本假设和展望考量;预期资本配置和支出金额及其对现金流的相应影响;关税和其他贸易限制的预期影响;有关其他矿业权益、资源、储量、项目和活动的计划和预期、复合年增长率、成本削减、转化网络优化、利润率改善、会计费用,以及与并非历史事实的事项相关的所有其他信息。可能导致Albemarle实际结果与任何前瞻性陈述中表达或暗示的展望存在重大差异的因素包括:经济和商业状况的变化;贸易政策和关税的变化;以及客户的财务和经营业绩;客户订单的时间和规模;碳酸锂当量和锂辉石市场价格的波动;潜在产量不足;竞争加剧和重新谈判合同条款的压力;产品或转化需求的变化;原材料和能源的可用性和成本;技术变革和发展;外币波动;法律和政府法规的变化;监管行动、程序、索赔或诉讼;网络安全漏洞、恐怖袭击、工业事故或自然灾害;将人工智能技术整合到我们运营中的相关风险;影响全球贸易的地缘政治冲突和政治动荡,包括中东紧张局势;全球经济和清洁能源倡议;我们留住关键人员和吸引新的熟练人员的能力;通胀或利率的变化;债务和股票市场的波动性和不确定性;收购和剥离交易;项目的时间安排和成功;新运营结构和资产优化活动的预期收益和费用;Albemarle在合资企业和其他项目中的合作伙伴的业绩;信用评级的变化;以及Albemarle不时向SEC提交的报告中详细说明的其他因素,包括Albemarle最近一份10-K表格年度报告以及随后提交的任何10-Q表格季度报告中“风险因素”项下所述的因素,这些报告已提交给SEC,可在Albemarle网站的投资者栏目(investors.albemarle.com)以及SEC网站www.sec.gov上查阅。这些前瞻性陈述仅代表本新闻稿发布之日的情况。除证券和其他适用法律另有要求外,Albemarle不承担在情况发生变化时对任何前瞻性陈述提供任何修订的义务。
雅宝(Albemarle)公司及子公司 合并利润表 (除每股金额外,单位为千美元)(未经审计) | |||||||
截至三个月 | 截至六个月 | ||||||
6月30日, | 6月30日, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
净销售额 | $ 1,743,313 | $ 1,329,992 | $ 3,172,044 | $ 2,406,873 | |||
销货成本 | 1,153,012 | 1,133,116 | 2,080,777 | 2,053,698 | |||
毛利 | 590,301 | 196,876 | 1,091,267 | 353,175 | |||
销售、一般及行政费用 | 126,353 | 132,457 | 263,759 | 255,959 | |||
重组费用及资产核销 | 7,337 | 4,448 | 33,203 | 3,385 | |||
研发费用 | 3,667 | 12,444 | 12,837 | 26,543 | |||
出售业务亏损 | — | — | 95,018 | — | |||
营业收入 | 452,944 | 47,527 | 686,450 | 67,288 | |||
利息及融资费用 | (30,924) | (49,939) | (64,045) | (98,916) | |||
其他收入(费用)净额 | 19,629 | (6,559) | 73,439 | 3,691 | |||
所得税及未合并投资净收益中的权益前收入(亏损) | 441,649 | (8,971) | 695,844 | (27,937) | |||
所得税费用 | 94,002 | 34,094 | 115,513 | 30,116 | |||
Income (loss) before equity in net income of | 347,647 | (43,065) | 580,331 | (58,053) | |||
未合并投资的净收益权益 | 151,564 | 78,258 | 247,857 | 142,544 | |||
净利润 | 499,211 | 35,193 | 828,188 | 84,491 | |||
归属于非控股权益的净利润 | (19,252) | (12,296) | (29,138) | (20,246) | |||
归属于雅宝(Albemarle Corporation)的净利润 | 479,959 | 22,897 | 799,050 | 64,245 | |||
强制性可转换优先股股息 | (41,687) | (41,687) | (83,375) | (83,375) | |||
归属于雅宝(Albemarle Corporation) | $ 438,272 | $ (18,790) | $ 715,675 | $ (19,130) | |||
归属于普通股 | $ 3.72 | $ (0.16) | $ 6.07 | $ (0.16) | |||
Diluted earnings (loss) per share attributable to | $ 3.52 | $ (0.16) | $ 5.87 | $ (0.16) | |||
加权平均流通普通股股数——基本 | 117,961 | 117,665 | 117,907 | 117,634 | |||
加权平均流通普通股—— | 136,212 | 117,665 | 136,170 | 117,634 | |||
雅宝公司(Albemarle Corporation)及子公司 简明合并资产负债表 (单位:千美元)(未经审计) | |||
6月30日, | 12月31日, | ||
2026 | 2025 | ||
资产 | |||
流动资产: | |||
现金及现金等价物 | $ 1,631,688 | $ 1,618,001 | |
应收账款 | 603,805 | 593,502 | |
其他应收款 | 123,870 | 105,110 | |
存货 | 1,384,563 | 1,179,271 | |
其他流动资产 | 200,275 | 140,440 | |
持有待售流动资产 | — | 371,815 | |
流动资产合计 | 3,944,201 | 4,008,139 | |
物业、厂房及设备 | 11,902,156 | 11,768,840 | |
减:累计折旧及摊销 | 3,442,831 | 3,156,429 | |
物业、厂房及设备净额 | 8,459,325 | 8,612,411 | |
投资 | 1,109,241 | 900,926 | |
其他资产 | 707,577 | 647,185 | |
商誉 | 1,482,672 | 1,499,657 | |
其他无形资产,扣除摊销 | 202,079 | 214,233 | |
持有待售非流动资产 | — | 491,660 | |
总资产 | $ 15,905,095 | $ 16,374,211 | |
负债和权益 | |||
流动负债: | |||
应付第三方账款 | $ 670,229 | $ 779,160 | |
应付关联方账款 | 445,421 | 134,369 | |
应计费用 | 507,556 | 521,831 | |
长期债务的当期部分 | 74,677 | 74,077 | |
应付股利 | 61,514 | 61,387 | |
应交所得税 | 131,703 | 35,467 | |
持有待售的流动负债 | — | 191,753 | |
流动负债合计 | 1,891,100 | 1,798,044 | |
长期债务 | 1,802,107 | 3,119,464 | |
退休后福利 | 45,198 | 44,744 | |
养老金福利 | 105,729 | 117,361 | |
其他非流动负债 | 1,158,555 | 1,084,892 | |
递延所得税 | 368,552 | 368,275 | |
持有待售非流动负债 | — | 59,970 | |
承诺和或有事项 | |||
权益: | |||
雅宝(Albemarle)公司股东权益: | |||
普通股 | 1,180 | 1,178 | |
强制可转换优先股 | 2,235,105 | 2,235,105 | |
额外实收资本 | 3,048,664 | 3,018,213 | |
累计其他综合亏损 | (243,599) | (334,807) | |
留存收益 | 5,233,819 | 4,613,676 | |
雅宝(Albemarle Corporation)股东权益总额 | 10,275,169 | 9,533,365 | |
非控股权益 | 258,685 | 248,096 | |
权益总额 | 10,533,854 | 9,781,461 | |
负债和权益总计 | $ 15,905,095 | $ 16,374,211 | |
雅宝(Albemarle)公司及子公司 部分合并现金流量数据 (单位:千美元)(未经审计) | |||
截至 6月30日的六个月 | |||
2026 | 2025 | ||
年初现金及现金等价物 | $ 1,618,001 | $ 1,192,230 | |
经营活动产生的现金流量: | |||
净利润 | 828,188 | 84,491 | |
将净利润调节为经营活动现金流量的调整项目: | |||
折旧与摊销 | 313,606 | 330,485 | |
出售业务损失 | 95,018 | — | |
出售股权投资收益 | (42,300) | — | |
股份支付及其他 | 14,661 | 17,068 | |
未合并投资的净收益权益(税后净额) | (247,857) | (142,544) | |
从非合并投资及非流通证券收到的股息 | 131,744 | 67,765 | |
养老金及退休后福利费用 | 5,299 | 3,504 | |
养老金及退休后缴款 | (14,298) | (9,934) | |
有价证券投资的未实现(收益)损失 | (2,792) | 4,984 | |
债务提前清偿收益 | (12,543) | — | |
递延所得税 | (19,798) | (38,907) | |
营运资金变动 | (53,125) | (96,762) | |
非流动负债变动及其他,净额 | 60,438 | 318,030 | |
经营活动提供的现金净额 | 1,056,241 | 538,180 | |
投资活动产生的现金流量: | |||
资本支出 | (170,407) | (302,252) | |
出售业务所得款项,扣除所售现金 | 525,156 | — | |
出售财产和设备所得款项 | — | 23,751 | |
出售投资所得款项 | 123,270 | — | |
出售可供出售债务证券所得款项 | — | 288,000 | |
(Payments) proceeds from settlement of foreign currency forward contracts, | (18,772) | 171,262 | |
有价证券销售净额 | 1,392 | 2,971 | |
对权益投资及非流通证券的投资 | (119) | (120) | |
投资活动提供的现金净额 | 460,520 | 183,612 | |
筹资活动产生的现金流量: | |||
长期债务和信贷协议的偿还 | (1,314,151) | (29,103) | |
长期债务及信贷协议借款所得 | 35,952 | 19,488 | |
其他债务偿还,净额 | (12,309) | (2,427) | |
与提前清偿债务相关的费用 | (1,686) | — | |
支付给普通股股东的股息 | (95,372) | (95,244) | |
支付给强制可转换优先股股东的股息 | (83,375) | (83,375) | |
支付给非控股权益的股息 | (37,463) | (18,169) | |
行使股票期权所得款项 | 19,635 | 1,186 | |
就股票薪酬奖励分配支付的预扣税 | (4,199) | (2,941) | |
Other | (438) | (55) | |
Net cash used in financing activities | (1,493,406) | (210,640) | |
Net effect of foreign exchange on cash and cash equivalents | (9,668) | 103,447 | |
Increase in cash and cash equivalents | 13,687 | 614,599 | |
Cash and cash equivalents at end of period | $ 1,631,688 | $ 1,806,829 | |
Albemarle Corporation and Subsidiaries Consolidated Summary of Segment Results (In Thousands) (Unaudited) | |||||||
Three Months Ended | Six Months Ended | ||||||
June 30, | June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net sales: | |||||||
Energy Storage | $ 1,276,684 | $ 717,656 | $ 2,167,849 | $ 1,242,221 | |||
Specialties | 423,484 | 351,560 | 781,897 | 672,574 | |||
Total segment net sales | 1,700,168 | 1,069,216 | 2,949,746 | 1,914,795 | |||
Corporate and all other | 43,145 | 260,776 | 222,298 | 492,078 | |||
Total net sales | $ 1,743,313 | $ 1,329,992 | $ 3,172,044 | $ 2,406,873 | |||
Adjusted EBITDA: | |||||||
Energy Storage | $ 723,457 | $ 219,725 | $ 1,274,813 | $ 406,080 | |||
Specialties | 117,720 | 72,977 | 193,849 | 131,643 | |||
Total segment adjusted EBITDA | 841,177 | 292,702 | 1,468,662 | 537,723 | |||
Corporate and all other | 16,920 | 43,773 | 53,249 | 65,896 | |||
Total adjusted EBITDA | $ 858,097 | $ 336,475 | $ 1,521,911 | $ 603,619 | |||
See accompanying non-GAAP reconciliations below.
Additional Information Regarding Non-GAAP Measures
It should be noted that adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, adjusted diluted income (loss) per share attributable to common shareholders, non-operating pension and other post-employment benefit ("OPEB") items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA (on a consolidated basis), EBITDA margin, adjusted EBITDA margin, operating cash flow conversion and net debt to adjusted EBITDA ratio are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net income attributable to Albemarle Corporation ("earnings") or other comparable measures calculated and reported in accordance with GAAP. These measures are presented here to provide additional useful measurements to review the company's operations, provide transparency to investors and enable period-to-period comparability of financial performance. The company's chief operating decision maker uses these measures to assess the ongoing performance of the company and its segments, as well as for business and enterprise planning purposes.
A description of other non-GAAP financial measures that Albemarle uses to evaluate its operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also is available on Albemarle's website at https://investors.albemarle.com. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company's results calculated in accordance with GAAP.
ALBEMARLE CORPORATION AND SUBSIDIARIES
Non-GAAP Reconciliations
(Unaudited)
See below for a reconciliation of adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted net income attributable to Albemarle Corporation is defined as net income attributable to Albemarle Corporation before the non-recurring, other unusual and non-operating pension and other post-employment benefit (OPEB) items as listed below. The non-recurring and unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, and other significant non-recurring items. Adjusted net income (loss) attributable to Albemarle Corporation common stockholders is defined as adjusted net income attributable to Albemarle Corporation after mandatory convertible preferred stock dividends. EBITDA is defined as net income attributable to Albemarle Corporation before interest and financing expenses, income tax expense (benefit), and depreciation and amortization. Adjusted EBITDA is defined as EBITDA plus or minus the proportionate share of Windfield Holdings income tax expense, non-recurring and other unusual items, and non-operating pension and OPEB items as listed below.
Three Months Ended | Six Months Ended | ||||||||||||||
June 30, | June 30, | ||||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||||
In thousands, except percentages and per | $ | % of | $ | % of | $ | % of | $ | % of | |||||||
Net income attributable to Albemarle | $479,959 | $ 22,897 | $ 799,050 | $ 64,245 | |||||||||||
Add back: | |||||||||||||||
Non-operating pension and OPEB items | 626 | 169 | 1,597 | 294 | |||||||||||
Non-recurring and other unusual items (net | 30,555 | 31,708 | 111,945 | 10,508 | |||||||||||
Adjusted net income attributable to Albemarle | 511,140 | 54,774 | 912,592 | 75,047 | |||||||||||
Mandatory convertible preferred stock | — | (41,687) | — | (83,375) | |||||||||||
Adjusted net income (loss) attributable to | $511,140 | $ 13,087 | $ 912,592 | $ (8,328) | |||||||||||
Adjusted diluted income (loss) per share | $ 3.75 | $ 0.11 | $ 6.70 | $ (0.07) | |||||||||||
Adjusted weighted-average common shares | 136,212 | 117,691 | 136,170 | 117,634 | |||||||||||
Net income attributable to Albemarle | $479,959 | 27.5 % | $ 22,897 | 1.7 % | $ 799,050 | 25.2 % | $ 64,245 | 2.7 % | |||||||
Add back: | |||||||||||||||
Interest and financing expenses | 30,924 | 1.8 % | 49,939 | 3.8 % | 64,045 | 2.0 % | 98,916 | 4.1 % | |||||||
Income tax expense | 94,002 | 5.4 % | 34,094 | 2.6 % | 115,513 | 3.6 % | 30,116 | 1.3 % | |||||||
Depreciation and amortization | 155,801 | 8.9 % | 168,731 | 12.7 % | 313,606 | 9.9 % | 330,485 | 13.7 % | |||||||
EBITDA | 760,686 | 43.6 % | 275,661 | 20.7 % | 1,292,214 | 40.7 % | 523,762 | 21.8 % | |||||||
Proportionate share of Windfield income | 70,766 | 4.1 % | 33,150 | 2.5 % | 112,300 | 3.5 % | 58,476 | 2.4 % | |||||||
Non-operating pension and OPEB items | 854 | — % | 336 | — % | 2,201 | 0.1 % | 611 | — % | |||||||
Non-recurring and other unusual items | 25,791 | 1.5 % | 27,328 | 2.1 % | 115,196 | 3.6 % | 20,770 | 0.9 % | |||||||
Adjusted EBITDA | $858,097 | 49.2 % | $ 336,475 | 25.3 % | $ 1,521,911 | 48.0 % | $ 603,619 | 25.1 % | |||||||
Net sales | $ 1,743,313 | $ 1,329,992 | $ 3,172,044 | $ 2,406,873 | |||||||||||
(a) Calculation of adjusted diluted income (loss) per share attributable to common shareholders for the three and six months ended June 30, 2026 excludes $41.7 million and $83.4 million, respectively, of mandatory convertible preferred stock dividends and includes the assumed conversion of preferred stock into the diluted shares outstanding, as this results in the more dilutive per share result. | |||||||||||||||
Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to Albemarle's operating segments and are included in the Corporate and all other category. In addition, the company believes that these components of pension cost are mainly driven by market performance, and the company manages these separately from the operational performance of the company's businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other income (expenses), net. Non-operating pension and OPEB items were as follows (in thousands):
Three Months Ended | Six Months Ended | ||||||
June 30, | June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Interest cost | $ 8,994 | $ 8,924 | $ 18,035 | $ 17,734 | |||
Expected return on assets | (8,140) | (8,588) | (15,834) | (17,123) | |||
Total | $ 854 | $ 336 | $ 2,201 | $ 611 | |||
In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle's adjusted net income (loss) calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):
Three Months Ended | Six Months Ended | ||||||
June 30, | June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Restructuring charges and asset write-offs(1) | $ 0.05 | $ 0.02 | $ 0.24 | $ 0.01 | |||
Acquisition and integration related costs(2) | 0.01 | 0.01 | 0.01 | 0.02 | |||
Loss on sale of business/equity investment, net(3) | — | — | 0.39 | — | |||
Gain on early extinguishment of debt(4) | — | — | (0.09) | — | |||
(Gain) loss in fair value of public equity securities(5) | (0.05) | — | (0.01) | 0.03 | |||
Other(6) | 0.17 | 0.13 | 0.20 | 0.05 | |||
Tax related items(7) | 0.04 | 0.11 | 0.08 | (0.02) | |||
Total non-recurring and other unusual items | $ 0.22 | $ 0.27 | $ 0.82 | $ 0.09 | |||
(1) | In 2026, the Company announced it would place Kemerton Train 1 into care and maintenance. As a result, and in addition to other previously announced restructuring actions, the Company recorded charges of $7.3 million and $33.2 million in Restructuring charges and asset write-offs for the three and six months ended June 30, 2026, respectively. Due to the impact of valuation allowances, this resulted in total after-tax charges of $7.5 million and $33.3 million, or $0.05 and $0.24 per share, for the three and six months ended June 30, 2026, respectively. The three and six months ended June 30, 2025 included certain restructuring costs and adjustments to previously recorded costs related to restructuring actions originally entered into in 2024. As a result, the Company recorded charges of $4.4 million and $3.4 million in Restructuring charges and asset write-offs and gains (losses) of $0.1 million and ($0.1) million in Other income (expenses), net for the three and six months ended June 30, 2025, respectively. Due to the impact of valuation allowances, this resulted in total after-tax gains of $2.9 million and $0.8 million, or $0.02 and $0.01 per share, for the three and six months ended June 30, 2025, respectively. |
(2) | Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three and six months ended June 30, 2026 were $0.8 million and $1.9 million ($0.01 and $0.01 per share, with no income tax effect due to the impact of valuation allowances), respectively, and for the three and six months ended June 30, 2025 were $1.8 million and $3.2 million ($1.4 million and $2.5 million after income taxes, or $0.01 and $0.02 per share), respectively. |
(3) | During the first quarter of 2026, the Company divested its controlling ownership interest in its Refining Solutions business and its full 50% ownership interest in the Eurecat joint venture. As a result of these transactions, the Company recorded a net loss of $52.7 million ($0.39 per share, with no income tax effect due to the impact of valuation allowances), representing the proceeds received less the carrying value as of the transaction dates. |
(4) | During the first quarter of 2026, the Company completed a $1.3 billion debt tender and redemption, resulting in a gain on early extinguishment of debt of $12.5 million ($0.09 per share, with no income tax effect due to the impact of valuation allowances), representing the repurchase of this debt at a discount, partially offset by tender premiums and redemption fees. |
(5) | Gains resulting from the net change in fair value of investments in public equity securities, recorded in Other income (expenses), net for the three and six months ended June 30, 2026 of $6.5 million and $1.0 million ($0.05 and $0.01 per share, with no income tax effect due to the impact of valuation allowances), respectively, and for the three and six months ended June 30, 2025 gains (losses) of $0.2 million and ($4.8) million ($0.1 million and ($3.8 million) after income taxes, or less than $0.01 and $0.03 per share), respectively. |
(6) | Other adjustments for the three months ended June 30, 2026 included amounts recorded in: |
| |
| |
| |
After income taxes, these net losses totaled $22.8 million, or $0.17 per share. | |
Other adjustments for the three months ended June 30, 2025 included amounts recorded in: | |
| |
| |
After income taxes, these net losses totaled $15.3 million, or $0.13 per share. | |
Other adjustments for the six months ended June 30, 2026 included amounts recorded in: | |
| |
| |
| |
After income taxes, these net losses totaled $27.0 million, or $0.20 per share. | |
Other adjustments for the six months ended June 30, 2025 included amounts recorded in: | |
| |
| |
After income taxes, these net losses totaled $5.4 million, or $0.05 per share. | |
(7) | Included in Income tax expense for the three and six months ended June 30, 2026 are discrete net tax expenses of $6.0 million and $10.6 million, or $0.04 and $0.08 per share, respectively, primarily related to the impact of foreign tax reserves and foreign return to provisions. |
Included in Income tax expense for the three and six months ended June 30, 2025 are discrete net tax expenses of $12.2 million, or $0.11 per share, and benefits of $2.0 million, or $0.02 per share, respectively, primarily related to the impact of foreign tax reserves and excess tax benefits realized from stock-based compensation arrangements. |
See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).
Income (loss) before | Income tax expense | Effective income tax | |||
Three months ended June 30, 2026 | |||||
As reported | $ 441,649 | $ 94,002 | 21.3 % | ||
Non-recurring, other unusual and non-operating pension and OPEB | 26,691 | (4,490) | |||
As adjusted | $ 468,340 | $ 89,512 | 19.1 % | ||
Three months ended June 30, 2025 | |||||
As reported | $ (8,971) | $ 34,094 | (380.0) % | ||
Non-recurring, other unusual and non-operating pension and OPEB | 27,664 | (4,213) | |||
As adjusted | $ 18,693 | $ 29,881 | 159.9 % | ||
Six months ended June 30, 2026 | |||||
As reported | $ 695,844 | $ 115,513 | 16.6 % | ||
Non-recurring, other unusual and non-operating pension and OPEB | 104,853 | (8,689) | |||
As adjusted | $ 800,697 | $ 106,824 | 13.3 % | ||
Six months ended June 30, 2025 | |||||
As reported | $ (27,937) | $ 30,116 | (107.8) % | ||
Non-recurring, other unusual and non-operating pension and OPEB | 21,381 | 10,579 | |||
As adjusted | $ (6,556) | $ 40,695 | (620.7) % |
See below for the calculation of operating cash flow conversion and a reconciliation of free cash flow, a non-GAAP measure, to net cash provided by operating activities, the most directly comparable financial measure calculated and reporting in accordance with GAAP. The Company defines operating cash flow conversion as Net cash provided by operating activities from the statement of cash flows divided by adjusted EBITDA, which is a non-GAAP measure. A reconciliation of adjusted EBITDA, the non-GAAP financial measure, from net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reporting in accordance with GAAP, is provided in the above tables (in thousands, except percentages).
Three Months Ended | |
June 30, 2026 | |
Free cash flow: | |
Net cash provided by operating activities | $ 709,997 |
Less: Capital expenditures | (71,731) |
Free cash flow | $ 638,266 |
Operating cash flow conversion: | |
Net cash provided by operating activities | $ 709,997 |
Adjusted EBITDA | $ 858,097 |
Operating cash flow conversion | 83 % |
See below for the calculation of the net debt to adjusted EBITDA ratio ("Consolidated Leverage Ratio," as defined in our credit agreement), a non-GAAP financial measure, for the twelve months ended June 30, 2026 (in thousands, except ratio).
Twelve Months Ended | |
June 30, 2026 | |
Adjusted EBITDA | $ 2,016,285 |
Equity in net income of non-Windfield Holdings unconsolidated investments (net of tax) | 544 |
Dividends received from non-Windfield Holdings unconsolidated investments | 9,804 |
Consolidated Windfield-Adjusted EBITDA | $ 2,026,633 |
Total Albemarle Corporation long-term debt (as reported) | $ 1,876,784 |
49% Windfield Holdings debt | 718,079 |
Off-balance sheet obligations and other | 95,200 |
Consolidated Windfield-Adjusted Funded Debt | $ 2,690,063 |
Less Cash | 1,631,688 |
Less 49% Windfield Holdings cash | 62,249 |
Consolidated Windfield-Adjusted Funded Net Debt | $ 996,126 |
Consolidated Leverage Ratio | 0.5 |
Contact: | |
|---|---|
1.980.308.6194 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-reports-second-quarter-2026-results-302844113.html
SOURCE Albemarle Corporation